Dana H. Bovbjerg, Ph.D.


UPMC Hillman Cancer Center






Research Interests

Biobehavioral factors in oncology; mind/brain and cancer.


Current Research Areas: The emotional, cognitive, behavioral, and biological consequences of cancer risk; the contribution of biobehavioral factors to side effects of cancer treatments (surgery, chemotherapy, radiotherapy) and interventions that may ameliorate those effects; psychosocial and experiential influences on cancer screening decisions; impact of psychological stress on DNA damage and repair; effects of lifestyle intervention on oxidative stress and telomere length. 

Accepting Graduate Students: Yes (contingent on funding)


  • PhD, University of Rochester School of Medicine and Dentistry


  • bov1

    Jenkins FJ, Van Houten B, Bovbjerg DH. Effects on DNA damage and/or repair processes as biological mechanisms linking psychological stress to cancer risk. J Appl Biobehav Res. 2014 Feb1;19(1):3-23. PubMed PMCID: PMC4039216

  • bov2

    Montgomery GH, David D, Kangas M, Green S, Sucala M, Bovbjerg DH, Hallquist MN, Schnur JB. Randomized controlled trial of a cognitive-behavioral therapy plus hypnosis intervention to control fatigue in patients undergoing radiotherapy for breast cancer. J Clin Oncol. 2014 Feb;32(6):557-63. PubMed PMCID: PMC3918539

  • bov3

    Linkov F, Burke LE, Komaroff M, Edwards RP, Lokshin A, Styn MA, Tseytlin E, Freese K, Bovbjerg DH. An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research. Gynecol Oncol. 2014 Apr;133(1):67-72. PubMed PMCID: PMC4340612

  • bov4

    Vin-Raviv N, Akinyemiju TF, Galea S, Bovbjerg DH. Depression and anxiety disorders among hospitalized women with breast cancer. PLOS ONE. 2015 Jun 2;10(6):e0129169. PubMed PMCID: PMC4452789.

  • bov6

    Low CA, Bovbjerg DH, Ahrendt S, Alhelo S, Choudry H, Holtzman M, Jones HL, Pingpank JF Jr, Ramalingam L, Zeh HJ 3rd, Zureikat AH, Bartlett DL. Depressive symptoms in patients scheduled for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: Prospective associations with morbidity and mortality. J Clin Oncol. 2016 Apr 10;34(11):1217-22. PubMed PMCID: PMC4872322. [Available 2017-02-10]

  • bov7

    Hershman DL, Kushi LH, Hillyer GC, Coromilas E, Buono D, Lamerato L, Bovbjerg DH, Mandelblatt JS, Tsai WY, Zhong X, Jacobson JS, Wright JD, Neugut AI. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat. 2016 May;157(1):133-43. PubMed PMCID: PMC4867255. [Available 2017-05-01]

  • bov8

    Edmond SN, Shelby RA, Keefe FJ, Fisher HM, Schmidt J, Soo MS, Skinner CS, Ahrendt GM, Manculich J, Sumkin JH, Zuley ML, Bovbjerg DH. Persistent breast pain among women with histories of breast conserving surgery for breast cancer compared to women without histories of breast surgery or cancer. Clin J Pain. 2017 Jan;33(1):51-56. PubMed PMCID: PMC5144924.